Abstract. The microRNA (miR/miRNA)-182/183/96 cluster comprises miR-96, -182 and -183. The present study examined five previous microarray-based human colon cancer miR expression profiling studies and the expression of these three miRs was found to be upregulated in colon cancer tissues. Subsequently, in vitro assays were performed to determine the role of the miR-183/182/96 cluster in colon cancer cells. The results demonstrated that inhibiting miR-183, miR-182 or miR-96 with antisense oligonucleotide (ASO)-mimics inhibited the proliferation of colon cancer cells. Notably, further investigation revealed that inhibiting their expression simultaneously led to a more efficient reduction in cancer cell proliferation. These results suggested that miR-182/183/96, which resides in clusters in the genome, functioned synergistically in colon cancer and implied that co-expression of the miR cluster ASOs was efficient in reducing tumorigenesis, offering novel insight into the use of miRNAs in tumor therapy.
Introduction
The survival rate of patients with colorectal cancer (CRC), which is one of the most common types of malignancy and the third leading cause of cancer-associated mortality worldwide, is delineated by a high rate of recurrence (1) (2) (3) . Mutations in certain tumor-suppressor genes and oncogenes have been identified, including adenomatous polyposis coli, deleted in colorectal cancer, mothers against decapentaplegic homolog 2 (Smad2), tumor protein 53 and kirsten rat sarcoma viral oncogene homolog (4) (5) (6) . These mutant genes have been used in CRC therapy; however, their treatment effectivity is limited. Therefore, further investigation of novel targeted therapeutics for the treatment of CRC is required.
Previous studies have revealed that micro (mi)RNAs can regulate tumor development by targeting their downstream genes and have been identified as a novel mechanism which contributes to the pathogenesis of CRC (7-9) has been identified. These small RNAs, which are aberrantly expressed in various types of cancer, act as oncogenes or tumor suppressors and are thus candidate targets for cancer therapy.
In the present study, the results of five microarray-based human colon cancer microRNA expression profiling studies were examined (10) (11) (12) (13) (14) (15) , comparing colon cancer tissue with normal tissue. The results demonstrated that the miR-183/96/182 cluster was upregulated in the colon cancer tissues. The miR-183/96/182 cluster contains three members: miR-183, miR-96 and miR-182. It has been reported that these miRNAs are located within a distance of 4 kb from each other on the mouse chromosome 6qA3 and are transcribed in the same direction. They are expressed coordinately and are important in the sensorineural fates of cells in the mouse inner ear (10, 11) . This miRNA cluster also has a significant role in the maintenance and survival of hair cells and post-mitotic photoreceptors of the retina (12) (13) (14) . In order to examine the roles of these miRNAs in the pathogenesis of CRC in the present study, a microarray-based miRNA expression profiling study was performed to compare miRNA expression levels in colon cancer and normal tissues. Furthermore, the present study aimed to investigate the importance of miR-183/182/96 in the proliferation of CRC cells using ASO-based miRNA inhibitors.
Materials and methods
Cell culture. HT-29 and LoVo human colon cancer cell lines were purchased from the American Type Culture Collection (Manassas, VA, USA). The cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Carlsbad, CA, USA) with 10% fetal calf serum (FCS; Sigma-Aldrich), 100 U/ml penicillin and 100 µg/ml streptomycin (Life Technologies). All the cells were maintained at 37˚C under an atmosphere of 5% CO 2 and 95% air. snRNA. Data processing was conducted using the SDS software (v2.1) (Applied Biosystems) and the expression levels of the miRNAs were then calculated using the 2 -ΔΔct method after normalized to the levels of U6snRNA.
MTT assay. The synthesized RNA duplexes of antiscrambled (ASO-miR-NC), ASO-miR-183, ASO-miR-182 and ASO-miR-96 mimics were obtained from GeneChem (Shanghai, China). Following transient transfection of miRNA inhibitors, the HT-29 or LoVo cells were seeded into 96-well plates at 1,500 cells/well and MTT (Sigma-Aldrich, St. Louis, MO, USA) assays were performed daily for 72 h. In this assay, the medium was replaced with fresh medium containing 0.5 mg/ml MTT for 4 h and then carefully removed. Subsequently, 150 µl dimethyl sulfoxide (Sigma-Aldrich) was added to each well and mixed for 10 min, and the optical density at 490 nm was determined using an enzyme linked immunosorbent assay reader (BioTek Instruments, Winooski, VT, USA). With the MTT we designed eight groups (A-H), which contained ASO-miR-183, ASO-miR-96, ASO-miR-182, either alone or in combinations of two or all three, as well as a ASO-miR-NC control group.
Colony formation assay. The cells were seeded into a 12-well plate at a density of 200 cells/well following transfection. The medium was changed every 3 days. After ~10 days, the majority of the cell clones contained >50 cells. The colonies were then washed with 1X phosphate-buffered saline and stained with crystal violet (Fisher Scientific, Pittsburgh, PA, USA) for ~5 min. Finally, images of the colonies were captured using a Nikon Eclipse E800 microscope (Nikon, Tokyo, Japan) and the number of colonies was counted. The colony formation rate (%) = (number of clones) / (number of seeded cells) x 100.
Western blot analysis. Western blot analysis was performed, as previously described (15) . Rabbit polyclonal anti-Ki-67 (ab15580) and Rabbit polyclonal anti p-protein kinase B (Akt; ab66138) were obtained from Abcam (Cambridge, MA, USA). Mouse monoclonal antibodies against Bcl 2-associated X protein (Bax; sc-20067) and p53 (sc-126) and horseradish peroxidase conjugated goat anti-mouse IgG (sc-2005) and goat anti-rabbit IgG (sc-2004) were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). The membranes were incubated with primary antibodies at 4 ºC overnight, followed by incubation with horseradish peroxidase-conjugated secondary antibodies. Proteins were then detected using an enhanced chemiluminescence kit (GE Healthcare Life Sciences, Piscataway, NJ, USA). LabWork 4.0 software was used to measure the band intensities of the blots.
Statistical analysis. All data are expressed as the mean ± standard deviation. The difference between groups was determined using two-tailed Student's t-test. Statistical analyses were performed using Micrsoft Excel 2013 (Microsoft Corp., Redmond, WA, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
All miR-183/96/182 cluster members are upregulated in colon cancer. The miR-183/96/182 cluster was located on the region of human chromosome 7q and the miRNAs were transcribed in the same direction. It has been suggested that this cluster is unregulated in colon cancer tissues. To confirm the expression levels of the members of this gene cluster in colon cancer, a total of five previous studies (Table I) (16) (17) (18) (19) (20) , which investigated miRNA expression in colon cancer, were examined and the fold changes of these three miRNAs in colon cancer tissues were compared with those in normal tissue. The clinical characteristics of these studies were extracted and are listed in Table I . All three miRNAs had ~2-fold changes in the colon cancer tissues according to the five microarray results. To confirm these findings, RNAs were extracted from eight colon cancer samples with paired adjacent normal colon tissues and these were analyzed by RT-qPCR (Fig. 1A-C) . Consistent with the Table I data, the results demonstrated that miR-183, miR-96 and miR-182 were expressed at relatively high levels in the colon cancer tissues.
Simultaneous knockdown of the expression of the miR-183/96/182 cluster efficiently inhibits HT-29 and LoVo cell viability compared with inhibiting the miRs alone.
It has been demonstrated that miR-183, 96 and 182 act as tumor oncogenes based on their high expression levels in colon cancer tissues (21) . Therefore, the present study used ASO-miRs to knockdown the expression of the miR-183/96/182 cluster. It has also been suggested that miR-183, miR-96 and miR-182 have similar sequences and are highly conserved across species, therefore, raising the question of whether the three miRNAs acted coordinately or competitively to regulate the growth phenotype of colon cancer. To address this question, the present study designed eight groups, defined as groups A-H, of ASO-miRNAs containing different concentrations of ASO-miR-183, ASO-miR-96, ASO-miR-182 and ASO-miR-NC, either alone or in combination (Fig. 2) . Subsequently, these ASO mimics were transfected into the HT-29 cells and the cell viability was measured using an MTT assay. As Fig. 2B shows, the HT-29 cell viability was classified into four levels. Arbitrary knockdown of two members of the miR-183/96/182 cluster (level 3) caused a reduction in HT-29 cell viability compared with the arbitrary knockdown of each alone (level 2). Furthermore, knockdown of all three members of the miR-183/96/182 cluster (group H) efficiently inhibited HT-29 cell viability (level 4) compared with the others (groups A-G). The same results were observed in the LoVo cells (Fig. 2C) . These results suggested that simultaneous knockdown of the expression of the miR-183/96/182 cluster efficiently inhibited colon cancer cell viability.
Simultaneous knockdown of the miR-183/96/182 cluster expression efficiently inhibits HT-29 cell colony formation ability compared with inhibition of the miRs alone. In the present study, an MTT assay was used to detect the colon cancer cell viability 72 h (Fig. 2B and C) after transfection with the ASO-miRNAs. To further confirm that simultaneous knockdown of all the members of the miR-183/96/182 cluster efficiently inhibited colon cancer cell viability compared with knockdown of the miRs alone, a colony formation assay was performed. According to the design of the MTT assay, eight transfection groups were used. As shown in Fig. 3A , the colony formation rates of the HT-29 cells transfected with ASO-miR-183, ASO-miR-96 or ASO-miR-182 (groups A, B, C and D) were lower compared with ASO-miR-NC (A). In addition, the cells simultaneously transfected with ASO-miR-183 and ASO-miR-96, ASO-miR-183 and ASO-miR-182 or ASO-miR-182 and ASO-miR-96 (groups E, F and G) had a higher colony formation rate compared with those simultaneously transfected with miR-183, miR-96 and miR-182 (group H). These results were consistent with those of the MTT assay, which demonstrated that simultaneous knockdown of the expression of the miR-183/96/182 cluster efficiently reduced HT-29 cell proliferation compared with inhibition of the miRs alone.
Simultaneous knockdown of the expression of the miR-183/96/182 cluster efficiently regulates key proliferation of colon cancer cells and expression of the apoptotic protein marker.
To investigate the effect of simultaneous knockdown of the expression of the miR-183/96/182 cluster on the proliferation/apoptotic signaling pathway, Ki-67, phosphorylated Table I . (p)-Akt, Bax and TP53 were examined by western blot analysis. In the HT-29 and LoVo cells, the combined inhibition of the miR-183 cluster increased the activated expression of wild-type p53 and Bax and decreased the expression of p-Akt and the cell proliferation marker Ki-67 (Fig. 4) . Collectively, the observation of induced apoptosis and decreased proliferation resulting from pooled knockdown of the miR-183 cluster in colon cells implied that treatment of colon cancer tumorigenesis using miRNA as a target in an miRNA-cluster-dependent manner may efficiently reduce colon cancer cell proliferation.
Discussion miRNAs, ~22 nt in length, are a novel class of regulatory molecules with the ability to control the expression levels of thousands of genes and appear to decrease the expression of proteins by increasing the degradation or suppressing the translation of mRNA (22) . Accumulating evidence indicates that miRNAs also function as oncogenes or tumor suppressor genes, which contribute to the tumorigenesis of several types of cancer, including colon cancer (23, 24) . In the present study, five eligible studies containing 196 samples and 15 CRC cell lines were examined. As listed in Table I , several dysregulated miRNAs were found, and subsequent investigation focused on the miR-183/96/182 cluster. Based on the data in Table I , the average expression levels of miR-183, miR-96 and miR-182 increased 2.30-, 2.31-and 3.03-fold, respectively, in colon cancer tissues compared with normal tissue.
The human miR-183/96/182 cluster is located on human chromosome 7q32. HIF1A  COX8A  VAMP8  JAK2  FOXO3  TP53  GFI1  PRPH2  TECTA  ARRDC3  PAK3  EIF2C1  BNIP3L  IL17A  NFIB  EGR1  HMOX1  NFIB  BTRC  FOXO1  ARRDC3  TBK1  MYD88  FOXO1  PNLIP  EVI1  FSCN1  KLF4  RET  ATOH1  ARIH2  CISH  PSAT1  HMGA2  FBXW7  ROS1  RDX  GJB6  IRS1  DICER1  RNASEH2A USF2  MTSS1  SAG  PRMT5  COX8A  MSH6  PIK3CA  EGR1  NEUROD4  HTR1B  FOXO3  HMG2L1  BCL2L11  RDX  ZEB2  NEUROD4 EIF2C1  SOX2  AKT1  RGS2  FXR1  POMC  MYC  RAC1  ERBB2  GEMIN4  MYB  TWIST1  PTEN  FOXO1  GFI1  RHOD  BCL2  MITF  PAK1  MYO15A  AKAP12  MLH1  CASP2  STAT6  LTBP1  SLC12A5 AKT1  DOK4  RNASEN  EGFR  KITLG  C2  ZEB1  MYCN  GEMIN4  BRAP  EGFR  ADCY6  FRAP1  IFI44  DOK4  HBEGF  TP53  ATOH1  SLC1A1  IL23A  ARRDC3  CDKN1A  SLC1A1  ATOH1  BBS9  ERBB2  EIF2C2  HPRT1  FBN1  MYC  MYB  NAMPT  SLC7A5  PI3  TMC1  RASA1  COX8A  DICER1  MYBL1  PITPNM1 ENPP3  E2F3  CCND1  TIA1  BRAF  ZEB1  EIF2C1  NEUROD4  GEMIN5  NCALD  DNTT  CDC42  ZEB1  MOS  PRB1  MSH2  CCND1  SSSCA1  RIT2  ADCY6  MTSS1  PAK3  RGS17  APC  CTNNB1  CCL27  MOS  AKT1  RNASEN  KRAS  KIT  SIRT1  EIF2C3  CASP2  CCND1  JAK2  SAG  HNF1A  IRS1  TIA1  SSSCA1  BHLHB5  ZNF828  RNPC3  ITGB1  EZR  FBXW7  HOMER1  DKK2  CREBZF  MYCN  BDNF  IRAK2  SLC26A4  DDX20  EIF2C2  DOK4  CAPNS1  STAT3  IL8  MOCOS  NRIP1  BAX  TNF  COL11A2 ELSPBP1  ADCY6  SOCS2  BCR  SIRT1  DICER1  HBEGF  CCL27  PDCD4  TP53  TIAM1  MITF  PTEN  SCPEP1  FABP4  EP300  IL17F  IL2  POU4F3  FBXW7  DFNB59  TGFB1  ZEB2  PRMT5  NEUROD4  RARG  EIF2C2  DICER1  HMGA2  MITF  KLK3  FOSB  CCND1  PRB1  BRCA1  CASP2  SFRS2  PTEN  STMN1  CASP2  EIF2C2  MOS  PCNA  MOS  ATOH1  SAG  COX8A  ATP8A2  FRAP1  TBP  PTPRR  CREB1  RELA  TNF  BIRC5  NRIP1  KRAS  ALK  SAG  DOK4  CD38  SOX6  CTTN  IDH2  KIF2A  ARRDC3  PRPH2  BBC3  SIP1  PTEN  SLC12A2  EIF2C1  ADCY6  GJB2  AMACR  CDKN1A  MAPK8  FSCN1  IGF2 bp1  RHOD  NPC1  FMR1  MCL1  FBXW7  NTRK1  AKT1  FOXO1  BCL2L11  CDKN1B  DDIT4  GRB2  FBN1  CA1  ZEB1  TP53  SOX9  GADD45A  EPB41L3  E2F3  DDX20  CDH17  CREB1  PPIA  CACNA2D2 MITF  MAP4K1 NR3C1 GPHN miR, microRNA.
that its overexpression is a marker for bladder cancer. Mihelich et al (26) identified the members of this cluster as having diagnostic and prognostic implications in prostate cancer. In addition, Yamada et al (27) identified two members of the cluster, miR-96 and miR-183 serve as potential tumor markers of urothelial carcinoma and Weeraratne et al (28) reported that the effects of the miR-183/96/182 cluster converge to regulate cell survival, proliferation and migration in medulloblastoma. The miR-183/96/182 cluster was also found to regulate oxidative apoptosis and sensitize cells to chemotherapy in gliomas (16, (25) (26) (27) (28) (29) . However, the effects of their coordinate expression on the mechanisms of tumorigenesis and particularly the proliferation of colon cancer remain to be fully elucidated. In the present study, this cluster was overexpressed in colon cancer, which was in accordance with a previous study (21) . A series of transfection oligo-nucleotides were designed to detect the effects of the miR-183/96/182 cluster in colon cancer. Notably, these miRNAs were observed to coordinately regulate the proliferation of colon cancer cells with a synergistic effect, which was termed 1 x ASO-miRNA = 1 x cell proliferation inhibition in the present study, however 3 x ASO-miRNA >3 x cell proliferation inhibition (Fig. 5) .
The results of the present study indicated that the combined biological effects of the three miRNAs in the miR-182/96/183 cluster possessed increased inhibitory properties compared with each individual miRNA alone. They exhibited the same directional transcription and highly conserved 'seed sequences' and acted as a unit that significantly regulated the phonotype of the colon cancer cells, similar to the results observed by Tang et al in glioma (29) . These findings provided support that miRNAs, which reside in clusters in the genome, function synergistically in cancer tumorigenesis. To further explain these mechanisms, the present study used the miRBASE database (http://www. mirbase.org/) to identify the targets of miR-182/96/183. As shown in Table II , 105 validated targets of miR-96, 81 targets of miR-182 and 90 targets of miR-183 were identified. However, only 20 targets were simultaneously targeted by all three miRNAs, which may explain why their simultaneous inhibition led to a synergistic increase in cell proliferation inhibition compared with inhibition of the miRNAs alone.
In conclusion, the present study demonstrated that increased expression of the miR-183/96/182 cluster was implicated in human colon cancer. Knockdown of the miR-183/96/182 cluster inhibited the survival of colon cancer cells and knockdown of the miR-183/96/182 cluster enhanced the anticancer proliferation effect more efficiently than knockdown of each alone. The co-expression of miRNA cluster ASOs may be a pleiotropic target for colon cancer therapy.
